Home‎ > ‎People‎ > ‎

Kile Green

Kile first joined the lab in May 2013 as a Masters student, working under the supervision of Professor Matt Collin on Alemtuzumab [CamPath] dosing in HSCTx patients. He received a grant from Bright Red in September 2013 to continue his work in the lab as a research technician with a particular focus on NanoString nCounter gene expression.  In January 2014 Kile enrolled as a PhD student under the supervision of Professor Matt Collin and Dr Venetia Bigley to investigate the gene expression profiles of dendritic cells along with in-vitro derived cells and GvHD affected samples.

Comments